Source: Blue Stem Prairie Author: Sally Jo Sorensen

video

While the Minnesota House Health Finance & Policy Committee heard Minneapolis Sydney Jordan’s bull, state representative Glenn Gruenhagen shared a personal story:

..My wife and I had COVID back in November. I was over it in about 48 hours, like a 48 hour flu, but my wife got very sick. She went to the doctor, they gave her prednisone and sent her home. Well, she took the prednisone for three or four days and it did seem to help some and once it was gone, the COVID got worse. In fact, it got to the point where she had a hard time breathing. 

Yet we didn’t see–they didn’t want to admit her to the hospital, so she went online to some doctors who–and explained her circumstances, [doctors] who prescribed her hydroxychloroquine and cpak, ok? We picked it up the next day at the local drugstore. She started taking that. Three-four days later she was better. This was where she was at where she had a hard time breathing, alright?

So my question to the testifiers is, …wouldn’t it make sense to give our most vulnerable population, where we have seventy percent of the deaths, preventative medication, like hydroxychloroquine and certain vitamins that were also recommended by these doctors, there’s –you can find them on the internet, there’s several medical experts that say, prevention for the most vulnerable should be done. You shouldn’t wait until you get sick to the point where you have to be hospitalized.

And yet that —it isn’t just my wife, I’ve had–and I’m a layperson, not a doctor, okay–but I’ve had several of my clients in my insurance industry tell me the same thing. Little was done until they had to be hospitalized. Why don’t we practice prevention?

Hydroxychloroquine can be sold over the counter without a prescription in Africa for malaria. It’s been around for over fifty years. So I’d like you to respond to that, one of the testifiers…





Related: Journal of Medicine Says HCQ + Zinc Reduces COVID Deaths

Yale doctor slams Fauci for his dismissal of hydroxychloroquine in COVID treatment

HCQ Peer-reviewed: Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection

HCQ and Ivermectin included in multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk COVID-19

Facebook Oversight Board admits Facebook was wrong to censor information about Hydroxychloroquine

COVID-19: A realistic approach to community management – HCQ & IVM in concert with vaccination

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »